Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

COR

Cencora Inc

Dec 24 • 04:00PM ET

227.54

Dollar change -0.10
Percentage change -0.04	%

Healthcare • Medical Distribution • USA • NYSE

Peers: CAH MCK HSIC OMI PDCO DXCM BIO HCA LH

| Held by: VTI VOO VO SPY COWZ IVV VTV VOE XLV VIG

Scroll to Statements

Index	S&P 500	P/E	30.32	EPS (ttm)	7.51	Insider Own	10.74%	Shs Outstand	194.94M	Perf Week	-0.04%
Market Cap	43.98B	Forward P/E	13.89	EPS next Y	16.38	Insider Trans	-18.08%	Shs Float	172.53M	Perf Month	-7.13%
Income	1.51B	PEG	3.33	EPS next Q	3.49	Inst Own	91.75%	Short Float	5.65%	Perf Quarter	1.84%
Sales	293.96B	P/S	0.15	EPS this Y	8.83%	Inst Trans	0.34%	Short Ratio	7.53	Perf Half Y	-4.10%
Book/sh	3.31	P/B	68.67	EPS next Y	9.39%	ROA	2.33%	Short Interest	9.76M	Perf Year	12.07%
Cash/sh	16.72	P/C	13.61	EPS next 5Y	9.10%	ROE	258.42%	52W Range	202.43 - 253.27	Perf YTD	10.79%
Dividend Est.	2.16 (0.95%)	P/FCF	14.67	EPS past 5Y	13.29%	ROI	27.50%	52W High	-10.16%	Beta	0.47
Dividend TTM	2.08 (0.91%)	Quick Ratio	0.53	Sales past 5Y	10.39%	Gross Margin	2.95%	52W Low	12.41%	ATR (14)	4.04
Dividend Ex-Date	Nov 15, 2024	Current Ratio	0.88	EPS Y/Y TTM	-12.10%	Oper. Margin	1.02%	RSI (14)	31.55	Volatility	1.31% 1.72%
Employees	46000	Debt/Eq	8.70	Sales Y/Y TTM	12.12%	Profit Margin	0.51%	Recom	1.89	Target Price	273.57
Option/Short	Yes / Yes	LT Debt/Eq	7.50	EPS Q/Q	-99.01%	Payout	27.07%	Rel Volume	0.30	Prev Close	227.64
Sales Surprise	1.84%	EPS Surprise	3.52%	Sales Q/Q	14.69%	Earnings	Nov 06 BMO	Avg Volume	1.29M	Price	227.54
SMA20	-4.25%	SMA50	-4.64%	SMA200	-2.61%	Trades		Volume	394,749	Change	-0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-21	Upgrade	BofA Securities	Underperform → Neutral
Jun-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$112
Apr-23-20	Resumed	Credit Suisse	Outperform	$105
Apr-01-20	Upgrade	JP Morgan	Neutral → Overweight	$93 → $106
Feb-07-20	Upgrade	Robert W. Baird	Neutral → Outperform	$112

Show Previous Ratings

Dec-16-24 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
Dec-14-24 06:35AM	Cencora price target lowered to $237 from $249 at Wells Fargo (TipRanks)
Dec-09-24 04:15PM	Cencora Closes $1.8 Billion Senior Notes Offering (Business Wire)
Dec-02-24 10:49PM	Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035 (Business Wire)
02:22PM	Here's Why Cencora (COR) is a Strong Momentum Stock (Zacks)
09:40AM	Loading…
Nov-25-24 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Nov-13-24 06:27PM	McKesson Stock Gets A RS Rating Lift To 75 (Investor's Business Daily)
09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Nov-11-24 09:50AM	Why Cencora (COR) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-08-24 03:37PM	Cardinal Health Stock Sees IBD RS Rating Improve To 71 (Investor's Business Daily)
Nov-07-24 07:01AM	Cencora Reports Strong Revenue and EPS Growth in 2024 (TipRanks)
06:36AM	Cencora to acquire Retina Consultants of America for $4.6B in cash (TipRanks)
Nov-06-24 03:07PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
06:35AM	Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results (Business Wire)
06:30AM	Loading…
06:30AM	Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America (Business Wire)
Nov-04-24 08:30AM	Cencora Expands Enterprise Leadership Team with Two Senior Appointments (Business Wire)
Oct-21-24 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Oct-15-24 12:10PM	Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Oct-11-24 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Oct-01-24 07:30AM	Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release (Business Wire)
Sep-27-24 07:00AM	Why Drug Distributors Are Buying Cancer Specialists (The Wall Street Journal)
Sep-18-24 07:10PM	Analyst Report: Cencora, Inc. (Morningstar Research)
12:37PM	Top Stock Movers Now: US Steel, VF Corp., ResMed, and More (Investopedia)
Aug-30-24 09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Aug-22-24 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
Aug-15-24 07:30AM	Cencora Elects Frank Clyburn to Its Board of Directors (Business Wire)
Aug-14-24 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Aug-05-24 05:48PM	S&P 500 Gains and Losses Today: Index Falls 3% as Economic Concerns Intensify (Investopedia)
Aug-02-24 12:51PM	Walgreens' latest stock sale raises about $1.1 billion (Chain Store Age)
12:00PM	Loading…
12:00PM	All You Need to Know About Cencora (COR) Rating Upgrade to Buy (Zacks)
11:51AM	Walgreens stock deal brings in about $1.1 billion (Chain Store Age)
Aug-01-24 06:17PM	Cencora Announces Common Share Repurchase From Walgreens Boots Alliance (Business Wire)
06:08PM	Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds (Business Wire)
Jul-31-24 04:44PM	Analyst Report: Cencora, Inc. (Morningstar Research)
06:30AM	Cencora Reports Fiscal 2024 Third Quarter Results (Business Wire)
Jul-30-24 09:50AM	Why Cencora (COR) is a Top Momentum Stock for the Long-Term (Zacks)
Jul-29-24 09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Jul-25-24 08:30AM	Do Options Traders Know Something About Cencora (COR) Stock We Don't? (Zacks)
Jul-12-24 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Jul-11-24 12:10PM	Why Cencora (COR) is Poised to Beat Earnings Estimates Again (Zacks)
07:00AM	The 7 Most Undervalued Dividend Stocks to Buy in July 2024 (InvestorPlace)
Jul-08-24 08:35AM	Outlook Therapeutics Announces UK MHRA Marketing Authorization of LYTENAVA (bevacizumab gamma) for the Treatment of Wet AMD (GlobeNewswire)
Jul-05-24 04:15PM	Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release (Business Wire)
Jul-03-24 03:50PM	3 Dividend Compounding Machines Poised for 30%+ Total Returns by 2026 (InvestorPlace)
Jun-28-24 08:03AM	Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Q3 2024 Earnings Call Transcript (Insider Monkey)
07:52AM	Cencora (COR) Stock Nosedives: Here's What Caused the Decline (Zacks)
Jun-26-24 07:44AM	Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now (Zacks)
Jun-25-24 07:30AM	3 Undervalued Gems Set to Soar 1,000% by 2026 (InvestorPlace)
Jun-24-24 08:28AM	Cencora (COR) Rose 19% in Q1 (Insider Monkey)
Jun-17-24 11:34AM	Cencora (COR) Gains 13.2% YTD: What's Driving the Stock? (Zacks)
Jun-10-24 09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Jun-02-24 04:00PM	Bulletproof Your Retirement: 3 Stocks That Will Stand the Test of Time (InvestorPlace)
May-31-24 11:31AM	Cencora (COR) Down 1.9% Since Last Earnings Report: Can It Rebound? (Zacks)
May-27-24 07:42AM	Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now (Zacks)
May-24-24 02:00PM	After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February (Benzinga)
May-23-24 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
May-22-24 05:44PM	Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance (Business Wire)
05:38PM	Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds (Business Wire)
May-15-24 05:17PM	11 Best Jim Cramer Stocks to Buy Now (Insider Monkey)
May-02-24 01:00PM	Cencora (NYSE:COR) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 10:00PM	Cencora (COR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:24PM	Analyst Report: Cencora, Inc. (Morningstar Research)
08:44AM	Cencora (COR) Q2 Earnings Top Estimates, 2024 View Raised (Zacks)
07:40AM	Cencora (COR) Q2 Earnings Top Estimates (Zacks)
06:30AM	Cencora Reports Fiscal 2024 Second Quarter Results (Business Wire)
Apr-26-24 09:15AM	Cencora (COR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
07:29AM	Cencora (COR) to Report Q2 Earnings: What's in the Cards? (Zacks)
Apr-15-24 09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
07:48AM	10 Best Low Volatility ETFs To Buy (Insider Monkey)
Apr-12-24 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Apr-05-24 08:30AM	Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release (Business Wire)
Apr-04-24 09:15AM	Cencora, Inc. (COR) Soars to 52-Week High, Time to Cash Out? (Zacks)
Apr-01-24 12:38PM	Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Q2 2024 Earnings Call Transcript (Insider Monkey)
Mar-29-24 09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
04:27AM	Cencora (COR) Reported a Strong Q4 and Rose 14% (Insider Monkey)
Mar-28-24 10:03AM	Tivic Health Systems, Inc. (NASDAQ:TIVC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
07:19AM	Reasons to Add Cencora (COR) Stock in Your Portfolio Now (Zacks)
Mar-19-24 09:48AM	Cencora (COR) Hits 52-Week High: What's Driving the Stock? (Zacks)
09:15AM	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? (Zacks)
Mar-13-24 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Mar-12-24 08:30AM	Cencora Announces Leadership Succession Plan (Business Wire)
Mar-08-24 03:13AM	15 Worst Performing Stocks in S&P 500 (Insider Monkey)
Mar-05-24 02:56AM	13 Best Pharma Dividend Stocks To Buy in 2024 (Insider Monkey)
Feb-28-24 12:00PM	Cencora (COR) Is Up 2.40% in One Week: What You Should Know (Zacks)
Feb-27-24 09:15AM	Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue? (Zacks)
Feb-14-24 04:18PM	Drug Shortages Trigger FTC Probe (The Wall Street Journal)
Feb-08-24 08:19PM	Walgreens sells shares in pharmaceutical distributor for $992 million (Chain Store Age)
09:15AM	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? (Zacks)
Feb-07-24 07:33PM	Walgreens Boots pockets $992 million after cutting Cencora stake for third time (Reuters)
06:26PM	Cencora Announces Common Share Repurchase From Walgreens Boots Alliance (Business Wire)
06:16PM	Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds (Business Wire)
01:11PM	Cencora Closes $500 Million Senior Notes Offering (Business Wire)
09:45AM	Cencora (COR) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
09:40AM	Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Feb-05-24 06:18PM	Cencora Prices $500 Million 5.125% Senior Notes Due 2034 (Business Wire)
Feb-04-24 07:50AM	Companies test out different ways to talk about ESG without saying 'ESG' (Yahoo Finance)
Feb-01-24 09:30AM	Cencora (COR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
Jan-31-24 07:11PM	Analyst Report: Cencora, Inc. (Morningstar Research) +5.51%

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Battaglia Silvana	Executive Vice President	Dec 20 '24	Sale	228.72	1,678	383,792	20,329	Dec 23 03:47 PM
Battaglia Silvana	Officer	Dec 20 '24	Proposed Sale	228.72	1,678	383,792		Dec 20 01:48 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 03 '24	Sale	250.41	1,816	454,754	21,988	Dec 04 04:22 PM
Krikorian Lazarus	Officer	Dec 03 '24	Proposed Sale	250.42	1,816	454,754		Dec 03 11:13 AM
Cleary James F	Chief Financial Officer	Nov 27 '24	Option Exercise	89.58	33,877	3,034,702	171,508	Dec 02 04:01 PM
COLLIS STEVEN H	Executive Chairman	Nov 25 '24	Sale	243.97	50,000	12,198,750	326,557	Nov 26 04:31 PM
COLLIS STEVEN H	Director	Nov 25 '24	Proposed Sale	243.98	50,000	12,198,760		Nov 25 04:04 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Option Exercise	89.58	21,509	1,926,776	328,261	Nov 21 04:49 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Sale	242.16	21,509	5,208,619	306,752	Nov 21 04:49 PM
COLLIS STEVEN H	Director	Nov 19 '24	Proposed Sale	242.16	21,509	5,208,619		Nov 19 10:00 AM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Oct 23 04:06 PM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Sale	235.80	21,509	5,071,822	285,088	Oct 23 04:06 PM
COLLIS STEVEN H	Officer	Oct 22 '24	Proposed Sale	235.80	21,509	5,071,822		Oct 22 10:43 AM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Sep 18 04:37 PM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Sale	241.01	21,509	5,183,884	285,088	Sep 18 04:37 PM
Lon Greenberg	Other: Board	Sep 17 '24	Proposed Sale	239.88	4,000	959,520		Sep 17 05:27 PM
COLLIS STEVEN H	Officer	Sep 17 '24	Proposed Sale	241.01	21,509	5,183,884		Sep 17 09:36 AM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Option Exercise	89.58	10,754	963,343	295,842	Aug 21 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Sale	239.13	10,754	2,571,604	285,088	Aug 21 04:08 PM
COLLIS STEVEN H	Officer	Aug 20 '24	Proposed Sale	239.13	10,754	2,571,604		Aug 20 10:47 AM
Battaglia Silvana	Executive Vice President	Aug 06 '24	Sale	242.69	1,473	357,482	10,948	Aug 07 04:09 PM
Battaglia Silvana	Officer	Aug 06 '24	Proposed Sale	242.69	1,473	357,483		Aug 06 02:08 PM
Walgreens Boots Alliance, Inc.	10% Owner	Aug 01 '24	Sale	240.56	4,438,171	1,067,646,416	19,980,000	Aug 05 06:44 PM
Walgreens Boots Alliance Holdi	Affiliate	Aug 01 '24	Proposed Sale	244.46	3,398,929	830,902,183		Aug 01 08:56 PM
COLLIS STEVEN H	Chairman, President & CEO	Jul 16 '24	Option Exercise	89.58	10,755	963,433	295,843	Jul 17 04:09 PM
COLLIS STEVEN H	Chairman, President & CEO	Jul 16 '24	Sale	222.12	10,755	2,388,901	285,088	Jul 17 04:09 PM
Donato Leslie E	EVP & Chief Strategy Officer	Jul 01 '24	Option Exercise	0.00	1,432	0	9,991	Jul 02 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	Jun 18 '24	Option Exercise	89.58	10,754	963,343	295,842	Jun 20 04:16 PM
COLLIS STEVEN H	Chairman, President & CEO	Jun 18 '24	Sale	235.76	10,754	2,535,363	285,088	Jun 20 04:16 PM
Clark Gina	Executive Vice President	May 31 '24	Sale	223.86	1,874	419,506	13,284	Jun 03 04:05 PM
Clark Gina	Executive Vice President	May 29 '24	Option Exercise	86.09	27,093	2,332,436	42,251	May 31 04:00 PM
Clark Gina	Executive Vice President	May 29 '24	Sale	216.07	27,093	5,853,985	15,158	May 31 04:00 PM
Clark Gina	Executive Vice President	Mar 18 '24	Sale	238.12	9,644	2,296,429	15,158	May 31 04:00 PM
DURCAN DERMOT MARK	Director	May 24 '24	Buy	218.58	500	109,290	21,876	May 29 04:02 PM
Walgreens Boots Alliance, Inc.	10% Owner	May 22 '24	Sale	215.12	1,859,390	400,000,158	24,418,171	May 24 04:05 PM
COLLIS STEVEN H	Chairman, President & CEO	May 21 '24	Option Exercise	89.58	10,755	963,433	295,843	May 22 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	May 21 '24	Sale	221.30	10,755	2,380,082	285,088	May 22 04:08 PM
Mauch Robert P.	Executive Vice President & COO	Apr 15 '24	Option Exercise	89.58	33,877	3,034,702	81,976	Apr 17 04:24 PM
Mauch Robert P.	Executive Vice President & COO	Apr 15 '24	Sale	235.09	57,564	13,532,721	24,412	Apr 17 04:24 PM
COLLIS STEVEN H	Chairman, President & CEO	Apr 16 '24	Option Exercise	89.58	10,754	963,343	295,842	Apr 17 04:23 PM
COLLIS STEVEN H	Chairman, President & CEO	Apr 16 '24	Sale	237.48	10,754	2,553,860	285,088	Apr 17 04:23 PM
COLLIS STEVEN H	Chairman, President & CEO	Mar 19 '24	Option Exercise	89.58	10,755	963,433	295,843	Mar 21 04:05 PM
COLLIS STEVEN H	Chairman, President & CEO	Mar 19 '24	Sale	240.21	10,755	2,583,459	285,088	Mar 21 04:05 PM
Campbell Elizabeth S	Executive Vice President	Mar 18 '24	Sale	238.12	6,977	1,661,363	8,246	Mar 20 04:23 PM
Clark Gina	Executive Vice President	Feb 13 '24	Sale	230.48	1,100	253,528	24,802	Feb 14 04:14 PM
Walgreens Boots Alliance, Inc.	10% Owner	Feb 07 '24	Sale	235.41	4,212,395	991,639,907	26,277,561	Feb 09 07:00 AM
GREENBERG LON R	Director	Jan 15 '24	Option Exercise	219.43	1,340	294,036	26,219	Jan 17 04:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COR

Cencora Inc

Upgrade your FINVIZ experience